Project 1 The nature of gene-by-diet interactions in obesity and other metabolic syndrome (MetSyn) traits is not well understood. Such interactions are likely to be key in understanding the worldwide ?epidemic of obesity?, particularly given the recent data implicating gut microbiota in cardio-metabolic traits. We propose a three- pronged approach to the problem. First, we will dissect gene-by-diet interactions affecting MetSyn traits (obesity, insulin resistance, fatty liver, plasma lipids) in a mouse population, the Hybrid Mouse Diversity Panel, that enables fine genetic mapping using association. Second, we will identify the underlying biochemical pathways using a systems genetics approach that allows us to follow the flow of information from DNA to transcriptome to proteome to metabolome to gut microbiome to MetSyn traits. Third, we will extend these findings to a human population, the METabolic Syndrome In Man (METSIM) study which consists of more than 10,000 men from Kuopio, Finland, that have been exquisitely characterized for MetSyn clinical traits, DNA variation and adipose tissue molecular phenotypes. The results will define mechanisms and genetic variations that underlie the striking divergent responses of individuals to unhealthy ?Western?-style diets rich in fat and sugar.
Project 1 Diets rich in fat and refined carbohydrates underlie much of the current ?epidemic of obesity? and thereby much of atherosclerosis, diabetes, and heart failure. An understanding of the genetic factors mediating dietary responses should enable the development of improved diagnostics and therapeutic approaches.
|Lang, Jennifer M; Pan, Calvin; Cantor, Rita M et al. (2018) Impact of Individual Traits, Saturated Fat, and Protein Source on the Gut Microbiome. MBio 9:|
|Cherlin, Svetlana; Wang, Maggie Haitian; Bickeböller, Heike et al. (2018) Detecting responses to treatment with fenofibrate in pedigrees. BMC Genet 19:64|
|Park, Shuin; Ranjbarvaziri, Sara; Lay, Fides D et al. (2018) Genetic Regulation of Fibroblast Activation and Proliferation in Cardiac Fibrosis. Circulation 138:1224-1235|
|Roberts, Adam B; Gu, Xiaodong; Buffa, Jennifer A et al. (2018) Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential. Nat Med 24:1407-1417|
|Zhu, W; Buffa, J A; Wang, Z et al. (2018) Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk. J Thromb Haemost 16:1857-1872|
|Lee, Jessica M; Ong, Jessica R; Vergnes, Laurent et al. (2018) Diet1, bile acid diarrhea, and FGF15/19: mouse model and human genetic variants. J Lipid Res 59:429-438|
|Miao, Zong; Alvarez, Marcus; Pajukanta, Päivi et al. (2018) ASElux: an ultra-fast and accurate allelic reads counter. Bioinformatics 34:1313-1320|
|Kurt, Zeyneb; Barrere-Cain, Rio; LaGuardia, Jonnby et al. (2018) Tissue-specific pathways and networks underlying sexual dimorphism in non-alcoholic fatty liver disease. Biol Sex Differ 9:46|
|Orozco, Luz D; Farrell, Colin; Hale, Christopher et al. (2018) Epigenome-wide association in adipose tissue from the METSIM cohort. Hum Mol Genet 27:1830-1846|
|Chella Krishnan, Karthickeyan; Kurt, Zeyneb; Barrere-Cain, Rio et al. (2018) Integration of Multi-omics Data from Mouse Diversity Panel Highlights Mitochondrial Dysfunction in Non-alcoholic Fatty Liver Disease. Cell Syst 6:103-115.e7|
Showing the most recent 10 out of 518 publications